These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32455343)

  • 21. CD28 and ICOS: similar or separate costimulators of T cells?
    van Berkel ME; Oosterwegel MA
    Immunol Lett; 2006 Jun; 105(2):115-22. PubMed ID: 16580736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AILIM/ICOS: its expression and functional analysis with monoclonal antibodies.
    Sakamoto S; Tezuka K; Tsuji T; Hori N; Tamatani T
    Hybrid Hybridomics; 2001; 20(5-6):293-303. PubMed ID: 11839247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD28 and ICOS play complementary non-overlapping roles in the development of Th2 immunity in vivo.
    Shilling RA; Clay BS; Tesciuba AG; Berry EL; Lu T; Moore TV; Bandukwala HS; Tong J; Weinstock JV; Flavell RA; Horan T; Yoshinaga SK; Welcher AA; Cannon JL; Sperling AI
    Cell Immunol; 2009; 259(2):177-84. PubMed ID: 19646680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blocking inducible co-stimulator in the absence of CD28 impairs Th1 and CD25+ regulatory T cells in murine colitis.
    de Jong YP; Rietdijk ST; Faubion WA; Abadia-Molina AC; Clarke K; Mizoguchi E; Tian J; Delaney T; Manning S; Gutierrez-Ramos JC; Bhan AK; Coyle AJ; Terhorst C
    Int Immunol; 2004 Feb; 16(2):205-13. PubMed ID: 14734605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical impact of ICOS signal in colorectal cancer patients.
    Zhang Y; Luo Y; Qin SL; Mu YF; Qi Y; Yu MH; Zhong M
    Oncoimmunology; 2016 May; 5(5):e1141857. PubMed ID: 27467961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CTLA4-Ig-Based Bifunctional Costimulation Inhibitor Blocks CD28 and ICOS Signaling to Prevent T Cell Priming and Effector Function.
    Goenka R; Xu Z; Samayoa J; Banach D; Beam C; Bose S; Dooner G; Forsyth CM; Lu X; Medina L; Sadhukhan R; Sielaff B; Sousa S; Tao Q; Touw D; Wu F; Kingsbury GA; Akamatsu Y
    J Immunol; 2021 Mar; 206(5):1102-1113. PubMed ID: 33495237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoregulatory molecules in patients with gestational diabetes mellitus.
    Pendeloski KP; Mattar R; Torloni MR; Gomes CP; Alexandre SM; Daher S
    Endocrine; 2015 Sep; 50(1):99-109. PubMed ID: 25754913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential CD28 and inducible costimulatory molecule signaling requirements for protective CD4+ T-cell-mediated immunity against genital tract Chlamydia trachomatis infection.
    Marks E; Verolin M; Stensson A; Lycke N
    Infect Immun; 2007 Sep; 75(9):4638-47. PubMed ID: 17635872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The landscape of
    de Vos L; Grünwald I; Bawden EG; Dietrich J; Scheckenbach K; Wiek C; Zarbl R; Bootz F; Landsberg J; Dietrich D
    Epigenetics; 2020 Nov; 15(11):1195-1212. PubMed ID: 32281488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The inducible costimulator plays the major costimulatory role in humoral immune responses in the absence of CD28.
    Suh WK; Tafuri A; Berg-Brown NN; Shahinian A; Plyte S; Duncan GS; Okada H; Wakeham A; Odermatt B; Ohashi PS; Mak TW
    J Immunol; 2004 May; 172(10):5917-23. PubMed ID: 15128772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparable in vivo efficacy of CD28/B7, ICOS/GL50, and ICOS/GL50B costimulatory pathways in murine tumor models: IFNgamma-dependent enhancement of CTL priming, effector functions, and tumor specific memory CTL.
    Zuberek K; Ling V; Wu P; Ma HL; Leonard JP; Collins M; Dunussi-Joannopoulos K
    Cell Immunol; 2003 Sep; 225(1):53-63. PubMed ID: 14643304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inducible costimulator (ICOS) up-regulation on activated T cells in chronic graft-versus-host disease after dog leukocyte antigen-nonidentical hematopoietic cell transplantation: a potential therapeutic target.
    Sato M; Storb R; Loretz C; Stone D; Mielcarek M; Sale GE; Rezvani AR; Graves SS
    Transplantation; 2013 Jul; 96(1):34-41. PubMed ID: 23694952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Regulatory function of tacrolimus and CsA on CD4/CD8 T lymphocyte subgroups and costimulators on them in allo-liver recipients].
    Bai YJ; Wang LL; Cai B; Zou YG; Feng WH; Yan LN
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Oct; 24(10):989-92. PubMed ID: 18845086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis?
    Bouwhuis MG; Gast A; Figl A; Eggermont AM; Hemminki K; Schadendorf D; Kumar R
    Cancer Immunol Immunother; 2010 Feb; 59(2):303-12. PubMed ID: 19672595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of increased CD8/CD28(null) T cells and alternative co-stimulatory molecules in chronic obstructive pulmonary disease.
    Hodge G; Mukaro V; Reynolds PN; Hodge S
    Clin Exp Immunol; 2011 Oct; 166(1):94-102. PubMed ID: 21910726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expansion of CD4+CD28- T cells producing high levels of interferon-{gamma} in peripheral blood of patients with multiple sclerosis.
    Miyazaki Y; Iwabuchi K; Kikuchi S; Fukazawa T; Niino M; Hirotani M; Sasaki H; Onoé K
    Mult Scler; 2008 Sep; 14(8):1044-55. PubMed ID: 18573819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis.
    Doubková M; Švancara J; Svoboda M; Šterclová M; Bartoš V; Plačková M; Lacina L; Žurková M; Binková I; Bittenglová R; Lošťáková V; Merta Z; Šišková L; Tyl R; Lisá P; Šuldová H; Petřík F; Pšikalová J; Řihák V; Snížek T; Reiterer P; Homolka J; Musilová P; Lněnička J; Palúch P; Hrdina R; Králová R; Hortvíková H; Strenková J; Vašáková M
    Clin Respir J; 2018 Apr; 12(4):1526-1535. PubMed ID: 28862397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28.
    Hutloff A; Dittrich AM; Beier KC; Eljaschewitsch B; Kraft R; Anagnostopoulos I; Kroczek RA
    Nature; 1999 Jan; 397(6716):263-6. PubMed ID: 9930702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eminent role of ICOS costimulation for T cells interacting with plasmacytoid dendritic cells.
    Janke M; Witsch EJ; Mages HW; Hutloff A; Kroczek RA
    Immunology; 2006 Jul; 118(3):353-60. PubMed ID: 16827896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction, binding specificity and function of human ICOS.
    Beier KC; Hutloff A; Dittrich AM; Heuck C; Rauch A; Büchner K; Ludewig B; Ochs HD; Mages HW; Kroczek RA
    Eur J Immunol; 2000 Dec; 30(12):3707-17. PubMed ID: 11169414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.